CZM reported a robust acceleration in sales in Q3 17/18 with broad-based growth across regions and business segments – momentum was driven by the strong traction for recently-launched products. While Microsurgery recorded a third consecutive quarter of double-digit growth (led by the US), the Ophthalmic Devices segment also entered double-digit territory (fuelled by the US and Asia-Pacific). Along with margin expansion of 140bp during the quarter, CZM remains on track to meet its revenu
13 Aug 2018
Momentum accelerates with broad-based growth across segments and regions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Momentum accelerates with broad-based growth across segments and regions
Carl Zeiss Meditec AG (AFX:WBO) | 0 0 1.8% | Mkt Cap: 4,494m
- Published:
13 Aug 2018 -
Author:
Sumit Sayal -
Pages:
3
CZM reported a robust acceleration in sales in Q3 17/18 with broad-based growth across regions and business segments – momentum was driven by the strong traction for recently-launched products. While Microsurgery recorded a third consecutive quarter of double-digit growth (led by the US), the Ophthalmic Devices segment also entered double-digit territory (fuelled by the US and Asia-Pacific). Along with margin expansion of 140bp during the quarter, CZM remains on track to meet its revenu